High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors.

The twin arginine translocation (Tat) pathway transports fully-folded and assembled proteins in bacteria, archaea and plant thylakoids. The Tat pathway contributes to the virulence of numerous bacterial pathogens that cause disease in humans, cattle and poultry. Thus, the Tat pathway has the potenti...

Full description

Bibliographic Details
Main Authors: Umesh K Bageshwar, Lynn VerPlank, Dwight Baker, Wen Dong, Shruthi Hamsanathan, Neal Whitaker, James C Sacchettini, Siegfried M Musser
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4764201?pdf=render
_version_ 1818197404824895488
author Umesh K Bageshwar
Lynn VerPlank
Dwight Baker
Wen Dong
Shruthi Hamsanathan
Neal Whitaker
James C Sacchettini
Siegfried M Musser
author_facet Umesh K Bageshwar
Lynn VerPlank
Dwight Baker
Wen Dong
Shruthi Hamsanathan
Neal Whitaker
James C Sacchettini
Siegfried M Musser
author_sort Umesh K Bageshwar
collection DOAJ
description The twin arginine translocation (Tat) pathway transports fully-folded and assembled proteins in bacteria, archaea and plant thylakoids. The Tat pathway contributes to the virulence of numerous bacterial pathogens that cause disease in humans, cattle and poultry. Thus, the Tat pathway has the potential to be a novel therapeutic target. Deciphering the Tat protein transport mechanism has been challenging since the active translocon only assembles transiently in the presence of substrate and a proton motive force. To identify inhibitors of Tat transport that could be used as biochemical tools and possibly as drug development leads, we developed a high throughput screen (HTS) to assay the effects of compounds in chemical libraries against protein export by the Escherichia coli Tat pathway. The primary screen is a live cell assay based on a fluorescent Tat substrate that becomes degraded in the cytoplasm when Tat transport is inhibited. Consequently, low fluorescence in the presence of a putative Tat inhibitor was scored as a hit. Two diverse chemical libraries were screened, yielding average Z'-factors of 0.74 and 0.44, and hit rates of ~0.5% and 0.04%, respectively. Hits were evaluated by a series of secondary screens. Electric field gradient (Δψ) measurements were particularly important since the bacterial Tat transport requires a Δψ. Seven low IC50 hits were eliminated by Δψ assays, suggesting ionophore activity. As Δψ collapse is generally toxic to animal cells and efficient membrane permeability is generally favored during the selection of library compounds, these results suggest that secondary screening of hits against electrochemical effects should be done early during hit validation. Though none of the short-listed compounds inhibited Tat transport directly, the screening and follow-up assays developed provide a roadmap to pursue Tat transport inhibitors.
first_indexed 2024-12-12T01:49:27Z
format Article
id doaj.art-84100f32452d4002873e775672a5c112
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T01:49:27Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-84100f32452d4002873e775672a5c1122022-12-22T00:42:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01112e014965910.1371/journal.pone.0149659High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors.Umesh K BageshwarLynn VerPlankDwight BakerWen DongShruthi HamsanathanNeal WhitakerJames C SacchettiniSiegfried M MusserThe twin arginine translocation (Tat) pathway transports fully-folded and assembled proteins in bacteria, archaea and plant thylakoids. The Tat pathway contributes to the virulence of numerous bacterial pathogens that cause disease in humans, cattle and poultry. Thus, the Tat pathway has the potential to be a novel therapeutic target. Deciphering the Tat protein transport mechanism has been challenging since the active translocon only assembles transiently in the presence of substrate and a proton motive force. To identify inhibitors of Tat transport that could be used as biochemical tools and possibly as drug development leads, we developed a high throughput screen (HTS) to assay the effects of compounds in chemical libraries against protein export by the Escherichia coli Tat pathway. The primary screen is a live cell assay based on a fluorescent Tat substrate that becomes degraded in the cytoplasm when Tat transport is inhibited. Consequently, low fluorescence in the presence of a putative Tat inhibitor was scored as a hit. Two diverse chemical libraries were screened, yielding average Z'-factors of 0.74 and 0.44, and hit rates of ~0.5% and 0.04%, respectively. Hits were evaluated by a series of secondary screens. Electric field gradient (Δψ) measurements were particularly important since the bacterial Tat transport requires a Δψ. Seven low IC50 hits were eliminated by Δψ assays, suggesting ionophore activity. As Δψ collapse is generally toxic to animal cells and efficient membrane permeability is generally favored during the selection of library compounds, these results suggest that secondary screening of hits against electrochemical effects should be done early during hit validation. Though none of the short-listed compounds inhibited Tat transport directly, the screening and follow-up assays developed provide a roadmap to pursue Tat transport inhibitors.http://europepmc.org/articles/PMC4764201?pdf=render
spellingShingle Umesh K Bageshwar
Lynn VerPlank
Dwight Baker
Wen Dong
Shruthi Hamsanathan
Neal Whitaker
James C Sacchettini
Siegfried M Musser
High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors.
PLoS ONE
title High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors.
title_full High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors.
title_fullStr High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors.
title_full_unstemmed High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors.
title_short High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors.
title_sort high throughput screen for escherichia coli twin arginine translocation tat inhibitors
url http://europepmc.org/articles/PMC4764201?pdf=render
work_keys_str_mv AT umeshkbageshwar highthroughputscreenforescherichiacolitwinargininetranslocationtatinhibitors
AT lynnverplank highthroughputscreenforescherichiacolitwinargininetranslocationtatinhibitors
AT dwightbaker highthroughputscreenforescherichiacolitwinargininetranslocationtatinhibitors
AT wendong highthroughputscreenforescherichiacolitwinargininetranslocationtatinhibitors
AT shruthihamsanathan highthroughputscreenforescherichiacolitwinargininetranslocationtatinhibitors
AT nealwhitaker highthroughputscreenforescherichiacolitwinargininetranslocationtatinhibitors
AT jamescsacchettini highthroughputscreenforescherichiacolitwinargininetranslocationtatinhibitors
AT siegfriedmmusser highthroughputscreenforescherichiacolitwinargininetranslocationtatinhibitors